Tenax Total Current Liabilities from 2010 to 2024

TENX Stock  USD 5.94  0.29  5.13%   
Tenax Therapeutics Total Current Liabilities yearly trend continues to be fairly stable with very little volatility. Total Current Liabilities is likely to outpace its year average in 2024. Total Current Liabilities is the total amount of liabilities that Tenax Therapeutics is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations. View All Fundamentals
 
Total Current Liabilities  
First Reported
1996-09-30
Previous Quarter
1.7 M
Current Value
2.6 M
Quarterly Volatility
1.6 M
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Tenax Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Tenax Therapeutics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 7.2 K, Other Operating Expenses of 8.4 M or Research Development of 3.6 M, as well as many indicators such as Price To Sales Ratio of 141.3 K, Dividend Yield of 3.31 or PTB Ratio of 0.71. Tenax financial statements analysis is a perfect complement when working with Tenax Therapeutics Valuation or Volatility modules.
  
Check out the analysis of Tenax Therapeutics Correlation against competitors.
For more information on how to buy Tenax Stock please use our How to Invest in Tenax Therapeutics guide.

Latest Tenax Therapeutics' Total Current Liabilities Growth Pattern

Below is the plot of the Total Current Liabilities of Tenax Therapeutics over the last few years. Total Current Liabilities is an item on Tenax Therapeutics balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Tenax Therapeutics are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. It is the total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations. Tenax Therapeutics' Total Current Liabilities historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Tenax Therapeutics' overall financial position and show how it may be relating to other accounts over time.
Total Current Liabilities10 Years Trend
Pretty Stable
   Total Current Liabilities   
       Timeline  

Tenax Total Current Liabilities Regression Statistics

Arithmetic Mean2,545,830
Geometric Mean2,278,755
Coefficient Of Variation51.23
Mean Deviation876,108
Median2,532,395
Standard Deviation1,304,230
Sample Variance1.7T
Range5.2M
R-Value0.14
Mean Square Error1.8T
R-Squared0.02
Significance0.62
Slope40,946
Total Sum of Squares23.8T

Tenax Total Current Liabilities History

20243.8 M
20233.6 M
20221.8 M
20211.6 M
20202.1 M
20192.5 M
20181.6 M

About Tenax Therapeutics Financial Statements

Tenax Therapeutics investors use historical fundamental indicators, such as Tenax Therapeutics' Total Current Liabilities, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Tenax Therapeutics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Total Current Liabilities3.6 M3.8 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Tenax Stock Analysis

When running Tenax Therapeutics' price analysis, check to measure Tenax Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tenax Therapeutics is operating at the current time. Most of Tenax Therapeutics' value examination focuses on studying past and present price action to predict the probability of Tenax Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tenax Therapeutics' price. Additionally, you may evaluate how the addition of Tenax Therapeutics to your portfolios can decrease your overall portfolio volatility.